Anoshirwan A. Tavakoli

Heidelberg University

Papers

1

Total Citations

3

H-Index

1

About

Anoshirwan A. Tavakoli is a leading figure in radiation oncology, with a specialized focus on stereotactic body radiotherapy (SBRT) for liver metastases and the long-term effects of such treatments on hepatic tissue. His major contribution lies in pioneering the use of magnetic resonance imaging (MRI) to characterize morphologic alterations in the liver following active motion-compensated SBRT, a critical advancement for optimizing multimodal cancer therapies. Through a multi-institutional pooled analysis published in 2023, Tavakoli demonstrated how MRI-based assessments can track subtle, long-term changes in normal liver tissue, providing essential data for refining treatment protocols and minimizing toxicity. This work, already garnering 3 citations, underscores his impact on bridging imaging science with clinical radiotherapy. Tavakoli’s research is instrumental for students and clinicians alike, offering a deeper understanding of how to balance tumor control with organ preservation. His achievements highlight a commitment to evidence-based, patient-centered care, making him a key voice in the evolving landscape of precision radiation oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Long-term characterization of MRI-morphologic alterations after active motion-compensated liver SBRT: a multi-institutional pooled analysis
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Heidelberg University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago